Trials / Completed
CompletedNCT00344409
A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients
A Double-blind, Placebo Controlled, Randomized Study of KRN321 for the Treatment of Anemia in Cancer Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
To compare the effectiveness of KRN321 to placebo in the treatment of anemia in cancer patients receiving multi cycle platinum-containing chemotherapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | darbepoetin alfa |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2007-05-01
- First posted
- 2006-06-26
- Last updated
- 2012-08-31
Locations
7 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00344409. Inclusion in this directory is not an endorsement.